Eligibility Ischemic Heart Disease NCT01203696

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
ischemic heart disease patient, and
Description

Myocardial Ischemia

Data type

boolean

Alias
UMLS CUI [1]
C0151744
given loading or maintenance dose of clopidogrel and in need of it for 1 or more month
Description

Clopidogrel Loading dose | Clopidogrel Maintenance dose

Data type

boolean

Alias
UMLS CUI [1,1]
C0070166
UMLS CUI [1,2]
C3714444
UMLS CUI [2,1]
C0070166
UMLS CUI [2,2]
C3714445
and in need of additional drug for optimal bp control (aim blood pressure <130/90) or angina control.
Description

Pharmaceutical Preparation Blood Pressure control | Blood pressure determination | Pharmaceutical Preparation Angina control

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0005823
UMLS CUI [1,3]
C0243148
UMLS CUI [2]
C0005824
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0421194
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
existing use of amlodipine
Description

Amlodipine

Data type

boolean

Alias
UMLS CUI [1]
C0051696
thrombocytopenia
Description

Thrombocytopenia

Data type

boolean

Alias
UMLS CUI [1]
C0040034
end stage renal failure
Description

Kidney Failure, Chronic

Data type

boolean

Alias
UMLS CUI [1]
C0022661
allergy to clopidogrel/ amlodipine
Description

Hypersensitivity Clopidogrel | Amlodipine allergy

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0070166
UMLS CUI [2]
C0570921
pregnancy/ lactation
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
strong inhibitor or inducer of cytochrome p450 3a4 enzyme within 7 days before start of the study.
Description

CYP3A4 Inhibitor Strong | CYP3A4 Inducer Strong

Data type

boolean

Alias
UMLS CUI [1,1]
C3830624
UMLS CUI [1,2]
C0442821
UMLS CUI [2,1]
C3830625
UMLS CUI [2,2]
C0442821

Similar models

Eligibility Ischemic Heart Disease NCT01203696

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Myocardial Ischemia
Item
ischemic heart disease patient, and
boolean
C0151744 (UMLS CUI [1])
Clopidogrel Loading dose | Clopidogrel Maintenance dose
Item
given loading or maintenance dose of clopidogrel and in need of it for 1 or more month
boolean
C0070166 (UMLS CUI [1,1])
C3714444 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C3714445 (UMLS CUI [2,2])
Pharmaceutical Preparation Blood Pressure control | Blood pressure determination | Pharmaceutical Preparation Angina control
Item
and in need of additional drug for optimal bp control (aim blood pressure <130/90) or angina control.
boolean
C0013227 (UMLS CUI [1,1])
C0005823 (UMLS CUI [1,2])
C0243148 (UMLS CUI [1,3])
C0005824 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C0421194 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Amlodipine
Item
existing use of amlodipine
boolean
C0051696 (UMLS CUI [1])
Thrombocytopenia
Item
thrombocytopenia
boolean
C0040034 (UMLS CUI [1])
Kidney Failure, Chronic
Item
end stage renal failure
boolean
C0022661 (UMLS CUI [1])
Hypersensitivity Clopidogrel | Amlodipine allergy
Item
allergy to clopidogrel/ amlodipine
boolean
C0020517 (UMLS CUI [1,1])
C0070166 (UMLS CUI [1,2])
C0570921 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy/ lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
CYP3A4 Inhibitor Strong | CYP3A4 Inducer Strong
Item
strong inhibitor or inducer of cytochrome p450 3a4 enzyme within 7 days before start of the study.
boolean
C3830624 (UMLS CUI [1,1])
C0442821 (UMLS CUI [1,2])
C3830625 (UMLS CUI [2,1])
C0442821 (UMLS CUI [2,2])